| Cohen & Steers Infrastructure Fund, Inc. (UTF) Notification of Sources of Distribution Under Section 19(a) |
NEW YORK , Feb. 27, 2025 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Infrastructure Fund, Inc. (NYSE: UTF) (the "Fund") with information regarding the sources of the distribution to be paid on February 28, 2025 and cumulative distributions paid fiscal year-to-date. In March 2015, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission. |
prnewswire.com |
2025-02-27 20:34:00 |
Czytaj oryginał (ang.) |
| Cohen & Steers Quality Income Realty Fund, Inc. (RQI) Notification of Sources of Distribution Under Section 19(a) |
NEW YORK , Feb. 27, 2025 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Quality Income Realty Fund, Inc. (NYSE: RQI) (the "Fund") with information regarding the sources of the distribution to be paid on February 28, 2025 and cumulative distributions paid fiscal year-to-date. In December 2012, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission. |
prnewswire.com |
2025-02-27 20:28:00 |
Czytaj oryginał (ang.) |
| Cohen & Steers REIT and Preferred and Income Fund, Inc. (RNP) Notification of Sources of Distribution Under Section 19(a) |
NEW YORK , Feb. 27, 2025 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers REIT and Preferred and Income Fund, Inc. (NYSE: RNP) (the "Fund") with information regarding the sources of the distribution to be paid on February 28, 2025 and cumulative distributions paid fiscal year-to-date. In December 2017, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission. |
prnewswire.com |
2025-02-27 20:20:00 |
Czytaj oryginał (ang.) |
| Cohen & Steers Total Return Realty Fund, Inc. (RFI) Notification of Sources of Distribution Under Section 19(a) |
NEW YORK , Feb. 27, 2025 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Total Return Realty Fund, Inc. (NYSE: RFI) (the "Fund") with information regarding the sources of the distribution to be paid on February 28, 2025 and cumulative distributions paid fiscal year-to-date. In December 2011, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission. |
prnewswire.com |
2025-02-27 20:19:00 |
Czytaj oryginał (ang.) |
| Cohen & Steers Closed-End Opportunity Fund, Inc. (FOF) Notification of Sources of Distribution Under Section 19(a) |
NEW YORK , Feb. 27, 2025 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Closed-End Opportunity Fund, Inc. (NYSE: FOF) (the "Fund") with information regarding the sources of the distribution to be paid on February 28, 2025 and cumulative distributions paid fiscal year-to-date. In December 2021, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission. |
prnewswire.com |
2025-02-27 19:43:00 |
Czytaj oryginał (ang.) |
| CNS Pharmaceuticals Provides Update on Current Cash Position and NASDAQ Listing |
Cash on hand provides over one year of runway to fund expected operations HOUSTON, TX / ACCESS Newswire / February 26, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today provided an update on its current cash position and discussed the completion of its recent initiative to maintain its listing on the NASDAQ Capital Market ("NASDAQ"). "As we kick off 2025, the Company has never been fundamentally stronger. |
accessnewswire.com |
2025-02-26 11:05:00 |
Czytaj oryginał (ang.) |
| Corero Network Security Strengthens Latin America Presence with Key Win and Growing Partner Network |
MARLBOROUGH, Mass. , Feb. 25, 2025 /PRNewswire/ -- As part of its strategic expansion in Latin America, Corero Network Security (AIM: CNS) (OTCQX: DDOSF), the distributed denial of service (DDoS) protection specialists, is deepening its commitment to the region through new partnerships and customer successes. |
prnewswire.com |
2025-02-25 09:00:00 |
Czytaj oryginał (ang.) |
| Cohen & Steers, Inc. Declares Quarterly Dividend |
NEW YORK , Feb. 20, 2025 /PRNewswire/ -- The Board of Directors of Cohen & Steers, Inc. (NYSE: CNS) declared a cash dividend for the first quarter of 2025 in the amount of $0.62 per share of common stock, representing a 5.1% increase from the $0.59 per share dividend last quarter. The dividend is payable on March 13, 2025 to stockholders of record as of the close of business on March 3, 2025. |
prnewswire.com |
2025-02-20 18:23:00 |
Czytaj oryginał (ang.) |
| CNS Pharmaceuticals to Present at the 18th Annual European Life Sciences CEO Forum |
Webcast presentation Wednesday, February 26th at 3:20 PM CET HOUSTON, TX / ACCESS Newswire / February 20, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that John Climaco, Chief Executive Officer of CNS Pharmaceuticals will present at the 18th Annual European Life Sciences CEO Forum on Wednesday, February 26, 2025 at 3:20 PM CET / 9:20 AM EST in Zurich, Switzerland. In addition to the presentation, management will be available to participate in one-on-one meetings with qualified members of the investor community who are registered to attend the conference. |
accessnewswire.com |
2025-02-20 11:00:00 |
Czytaj oryginał (ang.) |
| Trumpflation Positions Cohen & Steers Poorly Due To Real Estate And Preferred Focus |
Cohen & Steers (CNS) faces AUM declines due to asset depreciation in REITs and preferred shares amid persistent inflation affecting bond markets. This could be a portent for incoming outflows or inflow deceleration. At any rate, the macro changes don't favour long-duration asset ETFs that CNS focuses on. Despite positive net inflows, revenue growth was offset by rising expenses, resulting in flat EPS. |
seekingalpha.com |
2025-02-19 19:50:14 |
Czytaj oryginał (ang.) |
| CNS Pharmaceuticals, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference |
On-demand video webcast now available here HOUSTON, TX / ACCESS Newswire / February 19, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced it participated in the Virtual Investor "Top 5 for ‘25" On-Demand Conference. As part of the event, John Climaco, Chief Executive Officer of CNS Pharmaceuticals, presented the top five reasons of why he believes the investment community and industry colleagues should pay attention to the Company in 2025. |
accessnewswire.com |
2025-02-19 11:00:00 |
Czytaj oryginał (ang.) |
| CNS Pharmaceuticals Announces Reverse Stock Split |
HOUSTON, TX / ACCESS Newswire / February 19, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced a 1-for-50 reverse split of its common stock. Beginning on February 21, 2025, the Company's common stock will continue to trade on The Nasdaq Capital Market ("Nasdaq") on a split adjusted basis under the trading symbol "CNSP", but will trade under the following new CUSIP number: 18978H409. |
accessnewswire.com |
2025-02-19 10:30:00 |
Czytaj oryginał (ang.) |
| CNS Pharmaceuticals to Present at 6th Glioblastoma Drug Development Summit |
HOUSTON, TX / ACCESS Newswire / February 18, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced it will present at the 6th Glioblastoma Drug Development Summit being held February 18-20, 2025 in Boston, MA. As part of the event, Sandra Silberman, MD, PhD, Chief Medical Officer of CNS will give an oral presentation titled, "The Use of Traditional Chemotherapy with Activity In the Treatment of Glioblastoma: Novel Formulations of an Anthracylcine & a Taxane That Appear to Cross the Blood-Brain Barrier," on Thursday, February 20, 2025 at 10:45 AM ET. |
accessnewswire.com |
2025-02-18 11:00:00 |
Czytaj oryginał (ang.) |
| Cohen & Steers Announces Changes to Realty Indexes |
NEW YORK , Feb. 14, 2025 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) announced today pending changes to its Global Realty Majors Portfolio Index (GRM) and International Realty Majors Portfolio Index (IRP), effective as of the close of business on February 21, 2025. Cohen & Steers Global Realty Majors Portfolio Index (GRM) Added component (symbol) Removed component (symbol) Hongkong Land Holdings Ltd. |
prnewswire.com |
2025-02-14 18:05:00 |
Czytaj oryginał (ang.) |
| LG CNS Joins SAP Regional Strategic Services Partner Initiative in Asia Pacific |
Extending expertise in ERP consulting•implementation•operations across the region Driving client business innovation by integrating AI and cloud advancements into SAP's latest Cloud ERP solutions Delivering differentiated client value through LG CNS solutions such as 'PerfecTwin ERP Edition' and 'SINGLEX' SEOUL, South Korea , Feb. 14, 2025 /PRNewswire/ -- LG CNS today announced that it has joined SAP® Regional Strategic Services Partner (RSSP) initiative, established by SAP Asia Pacific (APAC) to amplify the capabilities and reach of established partners in the APAC region that are on a rapid growth trajectory. Through the RSSP initiative, SAP will provide strategic support to eligible partners, which may include coordinated industry-aligned solutions, joint go-to-market strategy, and access to SAP regional and market unit industry expertise. |
prnewswire.com |
2025-02-14 09:00:00 |
Czytaj oryginał (ang.) |
| Cohen & Steers Strengthens ETF Leadership with Griffin Frank and Alexander Berg |
NEW YORK , Feb. 11, 2025 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) is introducing Griffin Frank as Head of ETF Capital Markets and Alexander Berg as Head of ETF Sales, underscoring the firm's strategic expansion into the ETF marketplace. These appointments follow the firm's launch of three fully transparent Active ETFs focused on real estate, preferred securities, and natural resource equities. |
prnewswire.com |
2025-02-11 11:00:00 |
Czytaj oryginał (ang.) |
| CNS Pharmaceuticals to Present at the BIO CEO & Investor Conference |
In-person presentation today, February 10th at 1:15 PM ET HOUSTON, TX / ACCESS Newswire / February 10, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that John Climaco, Chief Executive Officer of CNS Pharmaceuticals will present at the BIO CEO & Investor Conference being held February 10-11, 2025 in New York, NY. Details of the presentation are as follows: Date: Monday, February 10, 2025 Presentation Time: 1:15 PM ET Location: Royale Room In addition to the presentation, management will be available to conduct one-on-one meetings and conference attendees that would like to schedule a meeting with the Company are encouraged to register through the BIO CEO attendee portal. |
accessnewswire.com |
2025-02-10 10:00:00 |
Czytaj oryginał (ang.) |
| Cohen & Steers Announces Preliminary Assets Under Management and Net Flows for January 2025 |
NEW YORK , Feb. 10, 2025 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today reported preliminary assets under management of $86.4 billion as of January 31, 2025, an increase of $598 million from assets under management of $85.8 billion at December 31, 2024. The increase was due to market appreciation of $960 million, partially offset by distributions of $149 million and net outflows of $213 million. |
prnewswire.com |
2025-02-10 09:10:00 |
Czytaj oryginał (ang.) |
| Corero Network Security Releases Multi-Site DDoS Protection Resiliency |
Automated DDoS-aware resiliency ensures uninterrupted service availability without complexity or excess cost MARLBOROUGH, Mass. , Feb. 6, 2025 /PRNewswire/ -- Corero Network Security (AIM: CNS) (OTCQX: DDOSF), the distributed denial of service (DDoS) protection specialists, today announced new advancements in multi-site resiliency and intelligent traffic management, further strengthening its ability to deliver always-on DDoS protection. |
prnewswire.com |
2025-02-06 09:00:00 |
Czytaj oryginał (ang.) |
| Cohen & Steers Launches Active ETFs |
NEW YORK , Feb. 5, 2025 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) announced today the launch of three fully transparent active ETFs trading on the NYSE Arca. The launch provides advisors and investors with access to the firm's flagship investment strategies through an active ETF vehicle. |
prnewswire.com |
2025-02-05 11:47:00 |
Czytaj oryginał (ang.) |
| Cohen & Steers Income Opportunities REIT, Inc. Acquires Open-Air Shopping Center in San Mateo, CA with Sterling Organization |
NEW YORK , Dec. 23, 2024 /PRNewswire/ -- Cohen & Steers Income Opportunities REIT, Inc. ("CNSREIT") announced today its acquisition of Bridgepointe Shopping Center, an open-air community shopping center in San Mateo, California. The acquisition was made through a programmatic joint venture with Sterling Organization ("Sterling"), a real estate investment firm with extensive expertise in shopping centers in the U.S. This is CNSREIT's third acquisition with Sterling Organization and fourth open-air shopping center acquisition in the portfolio. |
prnewswire.com |
2024-12-23 11:00:00 |
Czytaj oryginał (ang.) |
| Cohen & Steers Closed-End Funds Declare Distributions for January, February, and March 2025 |
NEW YORK , Dec. 18, 2024 /PRNewswire/ -- The Boards of Directors of the Cohen & Steers Closed-End Funds announced today the monthly distributions for January, February, and March 2025, as summarized in the charts below: Ticker Fund Name Monthly Dividend FOF Cohen & Steers Closed-End Opportunity Fund, Inc. $0.087 LDP Cohen & Steers Limited Duration Preferred and Income Fund, Inc. $0.131 PSF Cohen & Steers Select Preferred and Income Fund, Inc. $0.126 PTA Cohen & Steers Tax-Advantaged Preferred Securities and Income Fund $0.134 RFI Cohen & Steers Total Return Realty Fund, Inc. $0.080 RLTY Cohen & Steers Real Estate Opportunities and Income Fund $0.110 RNP Cohen & Steers REIT and Preferred and Income Fund, Inc. $0.136 RQI Cohen & Steers Quality Income Realty Fund, Inc. $0.080 UTF Cohen & Steers Infrastructure Fund, Inc. $0.155 Distributions will be made on the following schedule: Month Ex-Dividend/ Record Date Payable Date January Jan. 14, 2025 Jan. 31, 2025 February Feb. 11, 2025 Feb. 28, 2025 March Mar. 11, 2025 Mar. 31, 2025 Cohen & Steers Tax-Advantaged Preferred Securities and Income Fund, Cohen & Steers Real Estate Opportunities and Income Fund, Cohen & Steers Limited Duration Preferred and Income Fund, Inc., and Cohen & Steers Select Preferred and Income Fund, Inc. pay regular monthly cash distributions to common shareholders at a level rate that may be adjusted from time to time. Each of these fund's distributions reflect net investment income and may also include net realized capital gains and/or return of capital. |
prnewswire.com |
2024-12-18 21:27:00 |
Czytaj oryginał (ang.) |
| Cohen & Steers Closed-End Opportunity Fund, Inc. (FOF) Notification of Sources of Distribution Under Section 19(a) |
NEW YORK , Dec. 17, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Closed-End Opportunity Fund, Inc. (NYSE: FOF) (the "Fund") with information regarding the sources of the distribution to be paid on December 31, 2024 and cumulative distributions paid fiscal year-to-date. In December 2021, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission. |
prnewswire.com |
2024-12-17 21:14:00 |
Czytaj oryginał (ang.) |
| Cohen & Steers REIT and Preferred and Income Fund, Inc. (RNP) Notification of Sources of Distribution Under Section 19(a) |
NEW YORK , Dec. 17, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers REIT and Preferred and Income Fund, Inc. (NYSE: RNP) (the "Fund") with information regarding the sources of the distribution to be paid on December 31, 2024 and cumulative distributions paid fiscal year-to-date. In December 2017, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission. |
prnewswire.com |
2024-12-17 21:10:00 |
Czytaj oryginał (ang.) |
| Cohen & Steers Total Return Realty Fund, Inc. (RFI) Notification of Sources of Distribution Under Section 19(a) |
NEW YORK , Dec. 17, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Total Return Realty Fund, Inc. (NYSE: RFI) (the "Fund") with information regarding the sources of the distribution to be paid on December 31, 2024 and cumulative distributions paid fiscal year-to-date. In December 2011, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission. |
prnewswire.com |
2024-12-17 21:09:00 |
Czytaj oryginał (ang.) |
| Cohen & Steers Quality Income Realty Fund, Inc. (RQI) Notification of Sources of Distribution Under Section 19(a) |
NEW YORK , Dec. 17, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Quality Income Realty Fund, Inc. (NYSE: RQI) (the "Fund") with information regarding the sources of the distribution to be paid on December 31, 2024 and cumulative distributions paid fiscal year-to-date. In December 2012, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission. |
prnewswire.com |
2024-12-17 21:07:00 |
Czytaj oryginał (ang.) |
| Cohen & Steers Infrastructure Fund, Inc. (UTF) Notification of Sources of Distribution Under Section 19(a) |
NEW YORK , Dec. 17, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Infrastructure Fund, Inc. (NYSE: UTF) (the "Fund") with information regarding the sources of the distribution to be paid on December 31, 2024 and cumulative distributions paid fiscal year-to-date. In March 2015, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission. |
prnewswire.com |
2024-12-17 21:04:00 |
Czytaj oryginał (ang.) |
| Cohen & Steers Appoints Jon Cheigh as President |
NEW YORK , Dec. 17, 2024 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) has appointed Jon Cheigh as President, effective January 1, 2025. Mr. Cheigh remains Chief Investment Officer and will continue to focus the majority of his time on leading the investment department. |
prnewswire.com |
2024-12-17 10:00:00 |
Czytaj oryginał (ang.) |
| Corero Network Security to Present at Microcap Conference |
MARLBOROUGH, MA / ACCESSWIRE / December 12, 2024 / Corero Network Security (LSE:CNS)(OTCQX:DDOSF), the distributed denial of service (DDOS) protection specialists is pleased to announce its participation in The Microcap Conference 2025, the premier event for growth-focused companies and investors. The conference will take place January 28-30, 2025, at the Borgata Hotel Spa & Casino in Atlantic City, NJ. |
accesswire.com |
2024-12-12 11:30:00 |
Czytaj oryginał (ang.) |
| Cohen & Steers Announces Preliminary Assets Under Management and Net Flows For November 2024 |
NEW YORK , Dec. 9, 2024 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today reported preliminary assets under management of $91.4 billion as of November 30, 2024, an increase of $1.7 billion from assets under management of $89.7 billion at October 31, 2024. The increase was due to market appreciation of $1.9 billion, partially offset by distributions of $151 million and net outflows of $98 million. |
prnewswire.com |
2024-12-09 18:22:00 |
Czytaj oryginał (ang.) |
| Cohen & Steers Named a "Best Place to Work in Money Management" by Pensions & Investments for Fifth Consecutive Year |
NEW YORK , Dec. 9, 2024 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) announced today that it has been named as one of the "Best Places to Work in Money Management" for the fifth consecutive year by Pensions & Investments, a global news source of money management. P&I's 13th annual recognition program is dedicated to identifying and recognizing the best employers in the money management industry. |
prnewswire.com |
2024-12-09 11:00:00 |
Czytaj oryginał (ang.) |
| CNS Pharmaceuticals to Host Virtual Analyst & Investor Day on December 11, 2024 |
Live webcast discussion featuring internationally renowned Glioblastoma Multiforme (GBM) Key Opinion Leaders Company committed to addressing the most aggressive type of brain cancer with an average survival of only 14 to 16 months after diagnosis and no cure Register for the event here HOUSTON, TX / ACCESSWIRE / December 5, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced it will host a Virtual Analyst & Investor Day on Wednesday, December 11th from 11:30 AM - 1:00 PM ET. For the event, John Climaco, Chief Executive Officer, Sandra Silberman, MD, PhD, Chief Medical Officer and Zena Muzyczenko, Vice President of Clinical Operations at CNS Pharmaceuticals will be joined by Key Opinion Leaders: Michael Weller, Prof. |
accesswire.com |
2024-12-05 11:10:00 |
Czytaj oryginał (ang.) |
| RNP: Predictable Income From Cohen & Steers |
Cohen & Steers REIT & Preferred Income Fund offers a consistent monthly dividend, is managed by a professional team, and is diversified across REITs, preferred stocks, and fixed income. The RNP closed-end fund's quality portfolio and management justify consideration, depending on individual yield requirements. RNP has outperformed the real estate sector over the past decade, making it a reliable choice for income-focused investors. |
seekingalpha.com |
2024-11-26 20:28:02 |
Czytaj oryginał (ang.) |
| Cohen & Steers Closed-End Opportunity Fund, Inc. (FOF) Notification of Sources of Distribution Under Section 19(a) |
NEW YORK , Nov. 26, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Closed-End Opportunity Fund, Inc. (NYSE: FOF) (the "Fund") with information regarding the sources of the distribution to be paid on November 29, 2024 and cumulative distributions paid fiscal year-to-date. In December 2021, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission. |
prnewswire.com |
2024-11-26 19:59:00 |
Czytaj oryginał (ang.) |
| Cohen & Steers Total Return Realty Fund, Inc. (RFI) Notification of Sources of Distribution Under Section 19(a) |
NEW YORK , Nov. 26, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Total Return Realty Fund, Inc. (NYSE: RFI) (the "Fund") with information regarding the sources of the distribution to be paid on November 29, 2024 and cumulative distributions paid fiscal year-to-date. In December 2011, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission. |
prnewswire.com |
2024-11-26 19:58:00 |
Czytaj oryginał (ang.) |
| Cohen & Steers REIT and Preferred and Income Fund, Inc. (RNP) Notification of Sources of Distribution Under Section 19(a) |
NEW YORK , Nov. 26, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers REIT and Preferred and Income Fund, Inc. (NYSE: RNP) (the "Fund") with information regarding the sources of the distribution to be paid on November 29, 2024 and cumulative distributions paid fiscal year-to-date. In December 2017, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission. |
prnewswire.com |
2024-11-26 19:56:00 |
Czytaj oryginał (ang.) |
| Cohen & Steers Quality Income Realty Fund, Inc. (RQI) Notification of Sources of Distribution Under Section 19(a) |
NEW YORK , Nov. 26, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Quality Income Realty Fund, Inc. (NYSE: RQI) (the "Fund") with information regarding the sources of the distribution to be paid on November 29, 2024 and cumulative distributions paid fiscal year-to-date. In December 2012, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission. |
prnewswire.com |
2024-11-26 19:52:00 |
Czytaj oryginał (ang.) |
| Cohen & Steers Infrastructure Fund, Inc. (UTF) Notification of Sources of Distribution Under Section 19(a) |
NEW YORK , Nov. 26, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Infrastructure Fund, Inc. (NYSE: UTF) (the "Fund") with information regarding the sources of the distribution to be paid on November 29, 2024 and cumulative distributions paid fiscal year-to-date. In March 2015, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission. |
prnewswire.com |
2024-11-26 19:51:00 |
Czytaj oryginał (ang.) |
| CNS Pharmaceuticals Presents Update from Ongoing Potentially Pivotal Study of Berubicin Compared with Lomustine in Adult Patients with Recurrent GBM (WHO Grade IV) After Failure of Standard First Line Therapy |
Poster presented at the 29th Annual Meeting of the Society for Neuro-Oncology (SNO 2024) Primary analysis data in potentially pivotal GBM study with lead program, Berubicin, on track for the first half of 2025 HOUSTON, TX / ACCESSWIRE / November 25, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced the presentation of updated results from the on-going potentially pivotal study evaluating Berubicin, the Company's novel anthracycline and the first anthracycline to appear to cross the blood-brain barrier, in a randomized, controlled study vs. Lomustine, which has been considered to be a standard of care in this recurrent glioblastoma population. |
accesswire.com |
2024-11-25 11:00:00 |
Czytaj oryginał (ang.) |
| CORERO NETWORK SECURITY TAPS INDUSTRY VETERAN JUDSON THUERK TO LEAD CHANNEL STRATEGY IN THE AMERICAS |
MARLBOROUGH, Mass. , Nov. 25, 2024 /PRNewswire/ -- Corero Network Security (AIM: CNS) (OTCQX: DDOSF), the distributed denial of service (DDoS) protection specialists, announces the addition of Judson Thuerk to the Channel and Alliances Team as the Channel Manager for the Americas. |
prnewswire.com |
2024-11-25 09:00:00 |
Czytaj oryginał (ang.) |